Clin Gastroenterol Hepatol 2024;22:705-7.ArticlePubMed 29
In the age of genetically-modified autologous T cells used in 2nd line refractory multiple myeloma, the idea that a single peptide could treat almost everyone that was obese seemed incomprehensible, a Mad Men-esque throwback to the 90s with Prozac, Lipitor, and Viagra
It is important in the synthesis of collagen and elastin
Tirzepatide has been shown to: Lower blood sugar levels Improve insulin sensitivity Enhance cholesterol and triglyceride profiles These benefits help reduce the risk of obesity-related complications, such as cardiovascular disease, and support long-term health improvements for our patients
Less fat correlates with lower blood glucose levels, fewer heart attacks, less weight on aging hip and knee joints, improvement in fatty liver disease, delayed progression of diabetes-related kidney disease and more energy for day-to-day activities
This strength is commonly used in preliminary studies or experiments that need smaller amounts of the peptide